1. Home
  2. BIVI vs FCUV Comparison

BIVI vs FCUV Comparison

Compare BIVI & FCUV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIVI
  • FCUV
  • Stock Information
  • Founded
  • BIVI 2013
  • FCUV 2012
  • Country
  • BIVI United States
  • FCUV United States
  • Employees
  • BIVI N/A
  • FCUV N/A
  • Industry
  • BIVI Biotechnology: Pharmaceutical Preparations
  • FCUV Industrial Machinery/Components
  • Sector
  • BIVI Health Care
  • FCUV Industrials
  • Exchange
  • BIVI Nasdaq
  • FCUV Nasdaq
  • Market Cap
  • BIVI 14.2M
  • FCUV 15.9M
  • IPO Year
  • BIVI N/A
  • FCUV N/A
  • Fundamental
  • Price
  • BIVI $1.91
  • FCUV $3.70
  • Analyst Decision
  • BIVI
  • FCUV
  • Analyst Count
  • BIVI 0
  • FCUV 0
  • Target Price
  • BIVI N/A
  • FCUV N/A
  • AVG Volume (30 Days)
  • BIVI 184.5K
  • FCUV 41.7K
  • Earning Date
  • BIVI 11-12-2025
  • FCUV 11-06-2025
  • Dividend Yield
  • BIVI N/A
  • FCUV N/A
  • EPS Growth
  • BIVI N/A
  • FCUV N/A
  • EPS
  • BIVI N/A
  • FCUV N/A
  • Revenue
  • BIVI N/A
  • FCUV $432,983.00
  • Revenue This Year
  • BIVI N/A
  • FCUV N/A
  • Revenue Next Year
  • BIVI N/A
  • FCUV N/A
  • P/E Ratio
  • BIVI N/A
  • FCUV N/A
  • Revenue Growth
  • BIVI N/A
  • FCUV 140.82
  • 52 Week Low
  • BIVI $1.42
  • FCUV $1.80
  • 52 Week High
  • BIVI $75.00
  • FCUV $10.90
  • Technical
  • Relative Strength Index (RSI)
  • BIVI 46.41
  • FCUV 55.85
  • Support Level
  • BIVI $1.81
  • FCUV $3.14
  • Resistance Level
  • BIVI $2.07
  • FCUV $4.30
  • Average True Range (ATR)
  • BIVI 0.13
  • FCUV 0.45
  • MACD
  • BIVI 0.03
  • FCUV -0.01
  • Stochastic Oscillator
  • BIVI 37.99
  • FCUV 44.13

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

About FCUV Focus Universal Inc.

Focus Universal Inc offers smart devices, IoT products, and patented products and technologies for 5G telecommunications and network security. It is focused on commercializing its universal smart technology and financial reporting software. Its product line includes various digital, analog, and quantum light meters and filtration products, the Ubiquitor universal smart device, SEC Financial Reporting Software, and other smart devices and sensors. The company's reportable segments are Corporate and IoT, which derives maximum revenue, and Perfecular and Lusher. The Corporate and IoT segment includes its LED and IoT installation and management business (under Smart AVX), specializing in LED and display systems, home theaters, lighting control, automation, and integration.

Share on Social Networks: